Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
219.62
-4.92 (-2.19%)
At close: Jan 29, 2026, 4:00 PM EST
218.52
-1.10 (-0.50%)
Pre-market: Jan 30, 2026, 7:53 AM EST
Danaher Revenue
In the year 2025, Danaher had annual revenue of $24.57B with 2.90% growth. Danaher had revenue of $6.84B in the quarter ending December 31, 2025, with 4.59% growth.
Revenue (ttm)
$24.57B
Revenue Growth
+2.90%
P/S Ratio
6.37
Revenue / Employee
$389,968
Employees
63,000
Market Cap
155.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.57B | 693.00M | 2.90% |
| Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
| Dec 31, 2019 | 17.91B | 862.00M | 5.06% |
| Dec 31, 2018 | 17.05B | 1.53B | 9.86% |
| Dec 31, 2017 | 15.52B | -1.36B | -8.08% |
| Dec 31, 2016 | 16.88B | 2.45B | 16.97% |
| Dec 31, 2015 | 14.43B | 1.57B | 12.18% |
| Dec 31, 2014 | 12.87B | -5.42B | -29.62% |
| Dec 31, 2013 | 18.28B | 22.70M | 0.12% |
| Dec 31, 2012 | 18.26B | 2.17B | 13.49% |
| Dec 31, 2011 | 16.09B | 3.54B | 28.21% |
| Dec 31, 2010 | 12.55B | 2.03B | 19.33% |
| Dec 31, 2009 | 10.52B | -2.18B | -17.17% |
| Dec 31, 2008 | 12.70B | 1.67B | 15.16% |
| Dec 31, 2007 | 11.03B | 1.56B | 16.48% |
| Dec 31, 2006 | 9.47B | 1.59B | 20.26% |
| Dec 31, 2005 | 7.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thermo Fisher Scientific | 44.56B |
| IQVIA Holdings | 15.90B |
| Labcorp Holdings | 13.77B |
| Quest Diagnostics | 10.85B |
| Agilent Technologies | 6.95B |
| Illumina | 4.29B |
| IDEXX Laboratories | 4.17B |
| Mettler-Toledo International | 3.94B |
DHR News
- 1 day ago - Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Danaher Expects Gradual Improvement In End-Market Conditions - Benzinga
- 2 days ago - Danaher forecasts 2026 profit in line with estimates on pharma spending recovery - Reuters
- 2 days ago - Danaher Reports Fourth Quarter and Full Year 2025 Results - PRNewsWire
- 16 days ago - Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors - Seeking Alpha
- 17 days ago - Danaher CEO to Comment on Financial Performance - PRNewsWire
- 21 days ago - Danaher Is Ready to Put Its Post-Covid Malaise Behind It - Barrons